Delivery Order SPE2DB22D2005-SPE2DB24FJKW5
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of a medical product, "HYDROCORT-PRAMOXINE 2.5-1% CRM 30GM." The contract, valued at $4,424.93, has an ultimate completion date of April 8, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide a pharmaceutical product - Hydrocort-Pramoxine 2.5-1% Cream 30GM. The $2,002.93 contract has an ultimate completion date of April 12, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp to deliver a comprehensive range of...
- The U.S. government awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide HYDROCORT-PRAMOXINE 1%-1% CRM 30GM medical supplies. The $3,284.15 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a key agency for providing healthcare products to military and veterans' programs. The contract has an ultimate completion date of May 31, 2024 and is not designated as a set-aside. AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,545.65 to AmerisourceBergen Drug Corp for the supply of Hydrocort-Pramoxine 1%-1% cream in 30-gram quantities. This contract, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HYDROCORT-PRAMOXINE 2.5-1% CRM 30GM pharmaceutical products. The firm fixed price contract has a potential value of $1,310.86 and a completion date of January 11, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp, through its Corporate Office division, has an extensive history of providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.98 fixed-price delivery order is for the supply of HYDROCORT-PRAMOXINE 2.5-1% CRM 4GM, a pharmaceutical product. The contract has a period of performance through May 15, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
- This is a $1,434.24 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Hydrocortisone-Pramoxine 2.5-1% cream. The order has a completion date of September 18, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical through December 2025 for delivering a wide range of medical commodities to support military...
- The Defense Logistics Agency awarded a delivery order valued at $1,741.30 to AmerisourceBergen Drug Corp for Hydrocort-Pramoxine 1%-1% cream in 30-gram units. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of July 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Hydrocort-Pramoxine 2.5-1% cream in a 30-gram quantity, with a ceiling value of $3,264.15. This is a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and performance to be executed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively...
- The Defense Logistics Agency awarded a $3,778.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Hydrocort-Pramoxine 2.5-1% cream (28.4 grams) on August 27, 2025, with completion targeted for August 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was not set-aside and was competitively awarded....
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB24FJKW5Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply the federal government with HYDROCORT-PRAMOXINE 1%-1% CRM 30GM pharmaceuticals. The contract has an ultimate completion date of April 8, 2024 and a ceiling value of $2,708.39. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 4/5/24 |